Skip to main content
SpringerLink
Log in

Disease Management Update

  • From the World Literature
  • Published:
Disease Management & Health Outcomes

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. PharmacoEconomics & Outcomes News provides comprehensive coverage of the biomedical literature on health economics and outcomes research, and summarizes information selected from over 1600 journals.

  2. Costs were those related to physician services, medication, hospitalizations, rehabilitation, paramedics, laboratory tests, endoscopic procedures, abdominal ultrasounds and days off work, and were assessed mainly from a compulsory health insurance payor’s perspective.

  3. Assuming a 5% prevalence of IBS and annual costs of DM2000 per patient.

  4. Costs were those related to inpatient stay, staff salaries, community care, outpatient care, pediatric care. Costs accrued beyond the first year postpartum were discounted at a rate of 6% per annum.

References

1. Diabetes Disease Management Program Beneficial in the US

  • Swavely D, Merkle LN, Bub S, et al. A diabetes disease management model in the primary care setting. J Clin Outcomes Manag 2002 Dec; 9: 683–8.

    Google Scholar 

2. Asthma Management in Canada Inappropriate, Despite Guidelines

  • Lynd LD, Guh DP, Paré PD, et al. Patterns of inhaled asthma medication use: a 3-year longitudinal analysis of prescription claims data from British Columbia, Canada. Chest 2002 Dec; 122: 1973–81.

    Article  PubMed  Google Scholar 

3. Asthma Control, Quality of Life Better with Self-Management

  • Thoonen BPA, Schermer TRJ, van den Boom G, et al. Self-management of asthma in general practice, asthma control and quality of life: a randomised controlled trial. Thorax 2003 Jan; 58: 30–6.

    Article  PubMed  CAS  Google Scholar 

4. Irritable Bowel Syndrome Burden “Considerable” in Germany

  • Müller-Lissner SA, Pirk O. Irritable bowel syndrome in Germany: a cost of illness study. Eur J Gastroenterol Hepatol 2002 Dec; 14: 1325–9.

    Article  PubMed  Google Scholar 

5. Cost Burden of Postnatal Depression Significant in the UK

  • Petrou S, Cooper P, Murray L, et al. Economic costs of post-natal depression in a highrisk British cohort. Br J Psychiatry 2002 Dec; 181: 505–12.

    Article  PubMed  Google Scholar 

6. Benzodiazepine Use, Costs Reduced with Patient Education

  • Morgan JD, Wright DJ, Chrystyn H. Pharmacoeconomic evaluation of a patient education letter aimed at reducing long-term prescribing of benzodiazepines. Pharm World Sci 2002 Dec 24: 231–5.

    Article  PubMed  Google Scholar 

7. Disease Management Industry Looking Ahead to 2003

  • Stone R. DMAA leader predicts coming trends for DM industry. Dis Man News 2003 Jan; 8: 2, 25.

    Google Scholar 

8. Drug Compliance in the US Falls as Patient Copayments Rise

  • Bigger co-payments lead to falls in compliance, new US survey finds. Pharmaceut J 2003 Jan 18; 270: 69.

9. Sluggish Economy Spurs Rise in US 2001 Healthcare Spend

  • Levit K, Smith C, Cowan C, et al. Trends in U.S. health care spending, 2001: the rise in health care’s share of GDP is more a result of a slowing economy than of rising health spending. Health Aff 2003 Jan-Feb; 22: 154–64.

    Article  Google Scholar 

10. Suggestions for Improving the Australian PBS “Not a Panacea”

  • Lopert R, Henry D. The Pharmaceutical Benefits Scheme: economic evaluation works … but is not a panacea. Aust Prescriber 2002; 26(2): 126–7.

    Google Scholar 

11. Quality of Life Improves for Antibacterial Program Enrollees in Canada

  • Goodfellow AF, Wai AO, Frighetto L, et al. Quality-of-life assessment in an outpatient parenteral antibiotic program. Ann Pharmacother 2002 Dec; 36: 1851–5.

    Article  PubMed  Google Scholar 

12. Hospital Costs of Diabetes Mellitus Vary with Method Used to Attribute Costs

  • McCandless RR. Attributing inpatient Medicare costs to diabetes among the Texas elderly. Diabetes Care 2002 Nov; 25: 1958–63.

    Article  PubMed  Google Scholar 

13. Allergy Season Yields High Healthcare Costs in the US

  • Crystal-Peters J, Neslusan CA, Smith MW, et al. Health care costs of allergic rhinitisassociated conditions vary with allergy season. Ann Allergy Asthma Immunol 2002 Nov; 89: 457–62.

    Article  PubMed  Google Scholar 

14. Prescribing in Type 2 Diabetes Mellitus Changing in Sweden

  • Wändell PE, Gåfvels C. Drug prescription in men and women with type-2 diabetes in Stockholm in 1995 and 2001: change over time. Eur J Clin Pharmacol 2002 Nov; 58: 547–53.

    Article  PubMed  Google Scholar 

15. Quality of Care Improves for US Medicare Beneficiaries

  1. Jencks SF, Huff ED, Cuerdon T. Change in the quality of care delivered to Medicare beneficiaries, 1998–1999 to 2000–2001. JAMA 2003 Jan 15; 289: 305–12.

    Article  PubMed  Google Scholar 

  2. Hsia DC. Medicare quality improvement: bad apples or bad systems? JAMA 2003 Jan 15; 289: 354–6.

    Article  PubMed  Google Scholar 

16. Is Pharma to Blame for Soaring US Healthcare Costs?

  • Schlackman N. Determining the appropriate role of pharmaceuticals in a changing health care system. P & T 2002 Dec 2002; Suppl.: 4–6.

17. Disease Management Industry Expresses Interest in High-Risk Infant Management

  • Lippe G, Rose B, Norman G, et al. Health plans’ interest in infant care DM on the rise. Dis Manag News 2002 Dec 25; 8: 1, 4–5.

    Google Scholar 

18. Increasing Costs in Psychotic Disorders to Strain US Healthcare System

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Disease Management Update. Dis-Manage-Health-Outcomes 11, 271–276 (2003). https://doi.org/10.2165/00115677-200311040-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00115677-200311040-00007

Keywords

Search

Navigation